
Sign up to save your podcasts
Or


Join Drs Curigliano and Hurvitz as they discuss advances in systemic treatments for HER2-positive, triple-negative, and HR-positive breast cancer.
Credit available for this activity expires: [10/26/22]
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/961439?src=mkm_podcast_addon_961439
By Medscape Podcasts4
77 ratings
Join Drs Curigliano and Hurvitz as they discuss advances in systemic treatments for HER2-positive, triple-negative, and HR-positive breast cancer.
Credit available for this activity expires: [10/26/22]
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/961439?src=mkm_podcast_addon_961439

137 Listeners

320 Listeners

497 Listeners

102 Listeners

881 Listeners

13 Listeners

17 Listeners

288 Listeners

3,337 Listeners

1,154 Listeners

194 Listeners

88 Listeners

513 Listeners

366 Listeners

61 Listeners

25 Listeners

431 Listeners

370 Listeners